The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hercules are playing ball because if they pull the plug, they win and PIs lose everything. If they wait and it goes bust - same result. Either way, Hercules are getting all of this company.
No positive or holding Monday RNS tomorrow is really time to sjit yourself as a PI and sell whilst you can. There must SURELY have been frantic meetings over the weekend at Motif. By my reckoning is completely out of cash by now, if there's nothing on the cards with a lender is going to be suspended this week.
....travels fast in AIM, bad news is always slow to be delivered.
No RNS this morning boys and girls, UH OH!
No logical way for a drop? Other than the company is still at the mercy of its Lender and can't afford its loan payments? And its running out of cash? Still no update from the company on the exact cash position, last figure we had was 31 May. Time for an update, Lumsden.
Guess we'll find out whether or not Hercules pull the plug on Friday or Monday. No news by COB Monday on an extension is :S :S :S. Either way they get everything and shareholders get 0p whether they do it now or wait for admin.
Real question is - are Hercules going to pull the plug next week or just wait for the collapse?
What's your plan SeaDawg, wait for 0p?
You guys have lost it. Have you forgotten your drug has been rejected and you're out of cash at some point in the next 5 weeks. You better be praying Hercules doesn't pull the plug on you next week
An attempt at a pump to try and help get a funding round out. The company should be issuing an RNS on what the cash position is not this pointless dribble.
I think the Hercules payment was deferred to make it to September, otherwise why not approach them in June? Company needs to update the market on its cash position.
There are three things certain in life: death, taxes and Motif Bio going bust.
Literally the only possible funding option is death spiral at this late stage, which is like the stock being heavily shorted by the board everyone it needs cash.
You guys should phone IR and ask flatly does the company have enough cash to make it to the 19th September meeting? I bet you don't get a straight answer.
'I've lost so much on paper so there's no point in selling' is just a continuation of the poor risk management that holders have run to date. When approval was refused, the shares tanked and anyone could see the balance sheet and mcap were not enough to save this company. The risk: reward ratio is still poor. Another trial is needed the cost of which could exceed the mcap. That ALONE should tell you the equity is worthless as if you did receive funding you would still be diluted to oblivion. The company is 3-5 weeks from going bust with no funding on the horizon. The odds are heavily in favour of this being suspended imminently. To that extent you might as well realise your loss and take the Mrs out for a nice dinner with your £100 to say sorry before you can't even take her out for a KFC.
Company can't afford to make loan payments and is now at the mercy of the loan provider. All this does is confirm the cash situation is now CRITICAL. The fact that the board has not released the current cash balance really does mean things are grim. I wonder if there will be any winding up orders from suppliers imminent...
Yet the share goes up.
I think the only thing that could be pulled out the bag right now is death spiral financing, which makes it a slower death rather than a quick death for value in the equity. But the fact this isn't already sorted may indicated even those funders aren't interested, presumably worried about liquidity.
Zacks is an automatic traffic light system based on crude technical indicators. It is not proper independent research on fundamentals. No company would upgrade this piece of sjit given it's out of cash in 4-5 weeks and is getting booted off NASDAQ.
Where's the cash update GL? Tick follows tock...
The top will be when declared shorts closing out starts to drop off and there is slight weakness in the share price. At least that's what I'll be watching like a hawk over the coming days. A good short-term long purely because of the bear squeeze. Longer term - probably not. Not a good company.
Another day, another dump. Normality resumes.